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Mosquitoes are responsible for the transmission of several
pathogenic microorganisms to humans, causing mosquito-
borne diseases, such as malaria, dengue, yellow fever, West
Nile virus (WNV) disease, Chikungunya fever, and Rift Valley
fever (RVF). Although there are numerous native mosquito
species (e.g. Anopheles and Culex spp.) present and thus able to
transmit pathogens in Europe, other mosquito species (e.g.
Aedes spp.) have recently been introduced and become
established in the continent. Among them, the tiger mosquito,
Aedes albopictus, is probably the major threat to public health in
Europe. The presence of these tropical species means that
there is a risk of the appearance of autochthonous mosquito-
borne diseases that have previously never or rarely been seen
in Europe, acquired after importation from endemic countries
[1].
In the current themed section of CMI, four articles describe
the growing importance of mosquito-borne diseases in
Europe. The first article concerns five invasive Aedes mosquito
species that have already become established in Europe,
resulting in known and potential risks of local transmission of
rare pathogens. In the second article, an overview of different
types of surveillance and data collection with assessments of
mosquito-borne disease risks and trends is presented by
European Centre for Disease Prevention and Control (ECDC)
experts. The third article reports on some of the most
relevant aspects of WNV human infection, which has caused
numerous outbreaks during the last 20 years in Europe. The
fourth article describes the relevance of RVF, a mosquito-
borne zoonotic disease that affects both livestock and humans.
Schaffner et al. review five Asian aedine mosquito species
that have been discovered in Europe. Since the introduction of
invasive mosquitoes, above all A. albopictus, to Europe through
the used tyre trade and lucky bamboo plants, populations have
already become established locally, and are spreading further
[2]. As well as competent vectors, exotic pathogens are also
introduced by travel and trade [3]. Therefore, increasing
concern was evident after the outbreak of Chikungunya fever
in Italy in 2007 [4], and after confirmation of two autochtho-
nous Chikungunya virus infections in southern France in 2010
[5]. The threat of involvement of this mosquito species in the
transmission cycles of pathogens in the EU increased even
more after autochthonous cases of dengue fever occurred in
France and Croatia in 2010 [6,7]. However, dengue viruses are
commonly transmitted by the anthropophilic mosquito A. ae-
gypti, which was the vector implicated in the transmission of
dengue virus during the recent expansive epidemic of dengue
fever in Madeira in late 2012 [8]. The authors concluded that
there is a risk of the emergence of exotic mosquito-borne
diseases in the regions of Europe where A. albopictus or Aedes
aegypti are present [9]. Therefore, constant surveillance of
invasive mosquito populations is needed for prompt assess-
ment of the potential danger of future outbreaks.
Besides vector surveillance, human disease surveillance is
fundamental for the early detection of cases and for prompt
implementation of control measures. In the EU, tropical
mosquito-borne diseases are reportable communicable dis-
eases, and are thus covered by epidemiological surveillance
[10]. Zeller et al. describe an overview of different surveil-
lance activities of the ECDC to provide all member states with
estimations of mosquito-borne disease risks. They collect
various information through the specific expert networks
(European Surveillance System) and by event-based surveil-
lance, with the intention of enabling early detection of
potential public health dangers, allowing prompt and appro-
priate action. Through the laboratory network (European
Network for Diagnostic of Imported Viral Disease), the ECDC
provides continuous support for laboratory diagnostics in the
accurate detection and characterization of mosquito-borne
pathogens (e.g. Chikungunya virus, dengue virus, yellow fever
virus, WNV, and RVF). Complementary activities, such as
expert consultations, field missions, the preparation of guide-
lines and technical reports, and the production of updated
maps on the current known distributions of mosquito vector
species, represent additional ECDC programmes on mos-
quito-borne disease surveillance [11]. Finally, the authors
emphasize the need for coordinated human, veterinary,
entomological and environmental surveillance of mosquito-
borne diseases in Europe.
During the last 20 years, WNV has become the most
important mosquito-borne virus, being responsible for a
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increasing number of outbreaks in humans and horses within
the warmer regions of Europe [12]. WNV is naturally
transmitted in an avian cycle by mosquitoes of the genus
Culex. Humans and horses can also be infected incidentally, but
are considered to be dead-end hosts [13]. In a brief review,
Sambri et al. summarize the current epidemic situation of
WNV in Europe, the clinical features, the available diagnostic
tools, and possible preventive measures to control this rapidly
expanding mosquito-borne virus. The largest human WNV
epidemics occurred in Romania in 1996 and in the Russian
Federation in 1999 [14,15]. Over the years, sporadic human
cases or limited outbreaks of WNV disease have become
more frequent in southern European countries, such as Italy,
the Balkan countries, and above all, Greece. In addition,
concerns were raised after several reports of WNV transmis-
sion related to blood transfusion, or via organ donation,
were published [16]. The increasing number of WNF out-
breaks could be associated with the emergence of novel virus
strains with increased pathogenicity, and with significant
temperature deviations during the summer months [17,18].
As there is no licensed vaccine for WNV available, the present
preventive strategy is based on enhanced local disease
surveillance, ECED risk maps, and proper implementation of
control measures.
RVF, caused by the RVF virus, is a severe mosquito-borne
zoonosis affecting humans and livestock. Epidemics are
frequent in Africa, and are associated with severe health and
economic consequences [19]. Owing to the intensified legal or
illegal livestock trade, and probably in relation to climatic
changes, RVF virus has recently spread to the Middle East and
the Indian Ocean [20]. In the present themed section,
Chevalier discusses the low probability of the introduction
and spread of RVF in Europe. However, she emphasizes that
RVF outbreaks may occur in areas with favourable eco-climatic
conditions for competent mosquito vectors where a large
population of na€ıve ruminants is present. In such a scenario,
the first human cases would be recognized among farmers,
veterinarians, and slaughterhouse employees [21]. Although
surveillance and diagnostic methods are available, control and
preventive measures are still limited. Therefore, there is an
urgent need to develop more efficient surveillance and control
tools, and to support coordinated monitoring programmes,
particularly in the Mediterranean region, to enable prompt
recognition of the threat of potential introduction of RVF virus
into Europe.
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